Oleo Technologies / 12-Month Forecast Model / Internal

Month 12 Active Patients

Estimated enrolled MCAP patients in the supply book

Month 12 MRR

€0

Monthly recurring product supply revenue

AI Citation Count / mo

Modelled queries citing Oleo in AI engines

Consultant Re-Activations

Of the 22-prescriber historical base

Patient Count and Revenue Projection

Months 1 through 12. The dashed vertical line marks the Allwright Review trigger. Drag to re-time the inflection.

Four medical-specific levers. Adjust to test scenarios.

Active prescribers 34

Current base 22. Range covers +0 to +30 newly registered MCAP prescribers.

Avg patients per prescriber per month 2.5

Current 1.0. Higher implies broader condition acceptance under MCAP.

AI citation rate on MCAP queries 40%

Current 11%. Target band 30 to 70% as entity authority builds.

Allwright Review trigger Month 3

Department of Health expansion review. Drives the inflection.

Revenue per patient per month: €425 average product supply spend, sitting inside the €350 to €500 band observed across MCAP-comparable populations.
22-consultant lever: each re-activated historical prescriber is modelled to generate between 2 and 4 active patients at steady state, ramped over 4 months.
Allwright inflection: from the trigger month, prescriber growth and patient-per-prescriber rates step toward the slider targets along a smoothed curve. Pre-trigger months hold near the current baseline.
AI citation rate: applied to a modelled 1,200 monthly MCAP-related queries across ChatGPT, Perplexity, Google AI Overviews, and Claude.
Framing: all outputs reflect increased likelihood of supply uptake under modelled inputs. Nothing here constitutes a clinical or commercial guarantee.